Ivan K. Chinn

Ivan K. Chinn

Auto-generated profile, based on publicly available information

Ivan K. Chinn

Department of Pediatrics, Baylor College of Medicine, Houston, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2018 in Blood
Verified
Journal Article
Open access
PDF file
ICIvan K. Chinn
Ivan K. Chinn
OEOlive S. Eckstein
Olive S. Eckstein
EPErin C. Peckham-Gregory
Erin C. Peckham-Gregory
BGBaruch R. Goldberg
Baruch R. Goldberg
LFLisa R. Forbes
Lisa R. Forbes
CACarl E. Allen
Carl E. Allen
Key Points: Whole-exome sequencing may identify specific therapeutic opportunities for patients with HLH. HLH should be conceptualized as a critical illness phenotype driven by toxic activation of immune cells from different underlying mechanisms.

1 January 2020 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
ICIvan K. Chinn
Ivan K. Chinn
ACAlice Y. Chan
Alice Y. Chan
KCKarin Chen
Karin Chen
JCJanet Chou
Janet Chou
MDMorna J. Dorsey
Morna J. Dorsey
JWJolan E. Walter
Jolan E. Walter

10 July 2020 in Science
Verified
Journal Article
Closed access
PDF file
SCSarah A. Cook
Sarah A. Cook
WCWilliam A. Comrie
William A. Comrie
Cecilia Poli-HarloweCecilia Poli-Harlowe
Cecilia Poli-Harlowe
MSMorgan Similuk
Morgan Similuk
AOAndrew J. Oler
Andrew J. Oler
MLMichael J. Lenardo
Michael J. Lenardo
An inherited disorder makes WAVEs: The WAVE regulatory complex (WRC) is a multiunit complex that regulates actin cytoskeleton formation. Although other actin-regulatory proteins modulate human immune responses, the precise role for the WRC has not yet been established. Cook et al. studied five patients from four unrelated families who harbor missense variants of the gene encoding the WRC component HEM1. These patients presented with recurrent infections and poor antibody responses, along with enhanced allergic and autoimmune disorders. HEM1 was found to be required for the regulation of cortical actin and granule release in T cells and also interacted with a key metabolic signaling complex contributing to the disease phenotype. By linking these interactions to immune function, this work suggests potential targets for future immunotherapies. Science , this issue p. 202

1 January 2025 in Nature
Verified
Journal Article
Closed access
PDF file
OSO’jAy Stewart
O’jAy Stewart
CGConor Gruber
Conor Gruber
HRHaley E. Randolph
Haley E. Randolph
RPRoosheel Patel
Roosheel Patel
MRMeredith Ramba
Meredith Ramba
DBDusan Bogunovic
Dusan Bogunovic

9 December 2019 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JRJuan C. Ravell
Juan C. Ravell
MMMami Matsuda-Lennikov
Mami Matsuda-Lennikov
SCSamuel D. Chauvin
Samuel D. Chauvin
JZJuan Zou
Juan Zou
MBMatthew Biancalana
Matthew Biancalana
MLMichael J. Lenardo
Michael J. Lenardo
X-linked immunodeficiency with magnesium defect, EBV infection, and neoplasia (XMEN) disease are caused by deficiency of the magnesium transporter 1 (MAGT1) gene. We studied 23 patients with XMEN, 8 of whom were EBV naive. We observed lymphadenopathy (LAD), cytopenias, liver disease, cavum septum pellucidum (CSP), and increased CD4–CD8–B220–TCRαβ+ T cells (αβDNTs), in addition to the previously described features of an inverted CD4/CD8 ratio, CD4+ T lymphocytopenia, increased B cells, dysgammaglobulinemia, and decreased expression of the natural killer group 2, member D (NKG2D) receptor. EBV-associated B cell malignancies occurred frequently in EBV-infected patients. We studied patients with XMEN and patients with autoimmune lymphoproliferative syndrome (ALPS) by deep immunophenotyping (32 immune markers) using time-of-flight mass cytometry (CyTOF). Our analysis revealed that the abundance of 2 populations of naive B cells (CD20+CD27–CD22+IgM+HLA-DR+CXCR5+CXCR4++CD10+CD38+ and CD20+CD27–CD22+IgM+HLA-DR+CXCR5+CXCR4+CD10–CD38–) could differentially classify XMEN, ALPS, and healthy individuals. We also performed glycoproteomics analysis on T lymphocytes and show that XMEN disease is a congenital disorder of glycosylation that affects a restricted subset of glycoproteins. Transfection of MAGT1 mRNA enabled us to rescue proteins with defective glycosylation. Together, these data provide new clinical and pathophysiological foundations with important ramifications for the diagnosis and treatment of XMEN disease.

1 November 2015 in Immunology and Allergy Clinics of North America
Verified
Journal Article
Closed access
ICIvan K. Chinn
Ivan K. Chinn
WSWilliam T. Shearer
William T. Shearer